{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Surveillance sentinelle : Questions médicales les plus fréquentes",
"headline": "Surveillance sentinelle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Surveillance sentinelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-01",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Surveillance sentinelle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Surveillance de la population",
"url": "https://questionsmedicales.fr/mesh/D011159",
"about": {
"@type": "MedicalCondition",
"name": "Surveillance de la population",
"code": {
"@type": "MedicalCode",
"code": "D011159",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.780.675"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Surveillance sentinelle",
"alternateName": "Sentinel Surveillance",
"code": {
"@type": "MedicalCode",
"code": "D018571",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Camille Guillot",
"url": "https://questionsmedicales.fr/author/Camille%20Guillot",
"affiliation": {
"@type": "Organization",
"name": "Département de pathologie et microbiologie, Groupe de recherche en épidémiologie des zoonoses et santé publique (GREZOSP), Faculté de médecine vétérinaire, Université de Montréal, Québec, Canada."
}
},
{
"@type": "Person",
"name": "Catherine Bouchard",
"url": "https://questionsmedicales.fr/author/Catherine%20Bouchard",
"affiliation": {
"@type": "Organization",
"name": "Département de pathologie et microbiologie, Groupe de recherche en épidémiologie des zoonoses et santé publique (GREZOSP), Faculté de médecine vétérinaire, Université de Montréal, Québec, Canada."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Nivedita Gupta",
"url": "https://questionsmedicales.fr/author/Nivedita%20Gupta",
"affiliation": {
"@type": "Organization",
"name": "Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India."
}
},
{
"@type": "Person",
"name": "Patrick Leighton",
"url": "https://questionsmedicales.fr/author/Patrick%20Leighton",
"affiliation": {
"@type": "Organization",
"name": "Département de pathologie et microbiologie, Groupe de recherche en épidémiologie des zoonoses et santé publique (GREZOSP), Faculté de médecine vétérinaire, Université de Montréal, Québec, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Reproductive Outcomes of Conventional In Vitro Fertilization and Intracytoplasmic Sperm Injection in Patients with Non-Severe Male Infertility Across Poor and Different Sub-Optimal Ovarian Response Categories: A Cohort Study Based on 30,352 Fresh Cycles from 2009-2019.",
"datePublished": "2024-01-16",
"url": "https://questionsmedicales.fr/article/38228973",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s43032-023-01444-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Individual and community level factors associated with discriminatory attitudes against people living with HIV/AIDS among women of reproductive age in three sub-Saharan African countries: evidence from the most recent demographic and health survey (2021/22).",
"datePublished": "2024-06-05",
"url": "https://questionsmedicales.fr/article/38840148",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-19022-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of in vitro viral neutralization targets of highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) in alveolar macrophage and evaluation of protection potential against HP-PRRSV challenged based on combination of HP-PRRSV-structure proteins in vitro.",
"datePublished": "2024-03-05",
"url": "https://questionsmedicales.fr/article/38484577",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.vetmic.2024.110035"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35-40 years: A German database study.",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37320996",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bpobgyn.2023.102350"
}
},
{
"@type": "ScholarlyArticle",
"name": "In the presence of non-neutralising maternally derived antibodies, intradermal and intramuscular vaccination with a modified live vaccine against porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) induce similar levels of neutralising antibodies or interferon-gamma secreting cells.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36333756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40813-022-00289-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pratiques en santé publique",
"item": "https://questionsmedicales.fr/mesh/D015980"
},
{
"@type": "ListItem",
"position": 5,
"name": "Surveillance de la population",
"item": "https://questionsmedicales.fr/mesh/D011159"
},
{
"@type": "ListItem",
"position": 6,
"name": "Surveillance sentinelle",
"item": "https://questionsmedicales.fr/mesh/D018571"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Surveillance sentinelle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Surveillance sentinelle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Surveillance sentinelle",
"description": "Comment fonctionne la surveillance sentinelle ?\nQuels types de maladies sont surveillés ?\nQui participe à la surveillance sentinelle ?\nQuels outils sont utilisés pour la surveillance ?\nComment les données sont-elles analysées ?",
"url": "https://questionsmedicales.fr/mesh/D018571?mesh_terms=Reproduction&page=735#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Surveillance sentinelle",
"description": "Quels symptômes sont surveillés ?\nComment les symptômes sont-ils rapportés ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes varient-ils selon les régions ?\nComment les symptômes influencent-ils la surveillance ?",
"url": "https://questionsmedicales.fr/mesh/D018571?mesh_terms=Reproduction&page=735#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Surveillance sentinelle",
"description": "Quelles mesures préventives sont recommandées ?\nComment la surveillance aide-t-elle à la prévention ?\nLes campagnes de sensibilisation sont-elles efficaces ?\nComment les communautés peuvent-elles se préparer ?\nLes écoles jouent-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D018571?mesh_terms=Reproduction&page=735#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Surveillance sentinelle",
"description": "Quels traitements sont disponibles pour les maladies surveillées ?\nLa surveillance influence-t-elle les traitements ?\nComment les traitements sont-ils évalués ?\nY a-t-il des traitements préventifs ?\nLes traitements changent-ils avec les épidémies ?",
"url": "https://questionsmedicales.fr/mesh/D018571?mesh_terms=Reproduction&page=735#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Surveillance sentinelle",
"description": "Quelles complications peuvent survenir ?\nComment la surveillance aide-t-elle à prévenir les complications ?\nLes complications varient-elles selon les populations ?\nComment les complications sont-elles signalées ?\nLes complications influencent-elles les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D018571?mesh_terms=Reproduction&page=735#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Surveillance sentinelle",
"description": "Quels sont les facteurs de risque communs ?\nComment la surveillance identifie-t-elle les facteurs de risque ?\nLes facteurs de risque changent-ils avec le temps ?\nComment les facteurs de risque influencent-ils la surveillance ?\nLes comportements individuels affectent-ils les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D018571?mesh_terms=Reproduction&page=735#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment fonctionne la surveillance sentinelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle utilise des données de cas rapportés par des professionnels de santé pour identifier des tendances."
}
},
{
"@type": "Question",
"name": "Quels types de maladies sont surveillés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies infectieuses, les épidémies et les événements de santé publique sont surveillés."
}
},
{
"@type": "Question",
"name": "Qui participe à la surveillance sentinelle ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médecins, des hôpitaux et des laboratoires sont souvent impliqués dans ce système."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour la surveillance ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bases de données, des logiciels de gestion et des rapports de cas sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment les données sont-elles analysées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les données sont analysées statistiquement pour détecter des anomalies ou des tendances."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont surveillés ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon les maladies, incluant fièvre, toux, et diarrhée."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils rapportés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les professionnels de santé rapportent les symptômes observés chez les patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains symptômes comme la fièvre élevée peuvent indiquer une épidémie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les régions ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction des agents pathogènes locaux."
}
},
{
"@type": "Question",
"name": "Comment les symptômes influencent-ils la surveillance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes spécifiques peuvent déclencher une alerte et une investigation approfondie."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives sont recommandées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccinations, l'hygiène et la surveillance des symptômes sont recommandées."
}
},
{
"@type": "Question",
"name": "Comment la surveillance aide-t-elle à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'identifier rapidement les épidémies et d'initier des mesures préventives."
}
},
{
"@type": "Question",
"name": "Les campagnes de sensibilisation sont-elles efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent la connaissance des symptômes et des mesures préventives."
}
},
{
"@type": "Question",
"name": "Comment les communautés peuvent-elles se préparer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "En s'informant sur les maladies locales et en ayant des plans d'urgence."
}
},
{
"@type": "Question",
"name": "Les écoles jouent-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent éduquer les enfants sur l'hygiène et les symptômes des maladies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies surveillées ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements varient selon la maladie, incluant antiviraux et antibiotiques."
}
},
{
"@type": "Question",
"name": "La surveillance influence-t-elle les traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut guider les décisions de traitement en fonction des tendances épidémiques."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils évalués ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont évalués par des études cliniques et des rapports de résultats."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vaccins et des prophylaxies peuvent être utilisés pour prévenir certaines maladies."
}
},
{
"@type": "Question",
"name": "Les traitements changent-ils avec les épidémies ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des souches et des résistances."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves comme la pneumonie ou la déshydratation peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment la surveillance aide-t-elle à prévenir les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet une détection précoce des cas graves et une intervention rapide."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon les populations ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines populations peuvent être plus vulnérables à des complications spécifiques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles signalées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont signalées par les professionnels de santé dans le cadre de la surveillance."
}
},
{
"@type": "Question",
"name": "Les complications influencent-elles les traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent nécessiter des ajustements dans les traitements administrés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque communs ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le statut immunitaire et les conditions de vie."
}
},
{
"@type": "Question",
"name": "Comment la surveillance identifie-t-elle les facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle analyse les données épidémiologiques pour déterminer les populations à risque."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque changent-ils avec le temps ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent évoluer en fonction des changements environnementaux et sociaux."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque influencent-ils la surveillance ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à cibler les efforts de surveillance et à prioriser les interventions."
}
},
{
"@type": "Question",
"name": "Les comportements individuels affectent-ils les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements comme le tabagisme ou l'alimentation peuvent augmenter les risques."
}
}
]
}
]
}
Due to the influence of economic, social and many other factors, there are more and more reproductive problems. Originally introduced for managing male factor infertility, intracytoplasmic sperm injec...
HIV-related stigma and discrimination significantly affects health, and well-being, willingness to be tested for HIV, initiation and adherence to antiretroviral therapy, and quality of life. However, ...
The appended and most recent Demographic and Health Survey dataset of three sub-Saharan African countries from 2021 to 2022 was used for data analysis. A total of 56,690 women aged 15-49 years were in...
The overall prevalence of discriminatory attitudes against people living with HIV/AIDS was 28.19% (95% CI: 27.74%, 28.64%). In the multivariable analysis, individual level (being young, being an inter...
The prevalence of discriminatory attitudes against people living with HIV/AIDS in three sub-Saharan African countries was high. Individual and community-level variables were associated with discrimina...
Porcine reproductive and respiratory syndrome virus (PRRSV) poses a significant threat to the global pork industry, resulting in substantial economic losses. Current control measures rely on modified ...
This non-interventional study compared the effectiveness of recombinant human follicle-stimulating hormone (r-hFSH) and recombinant human luteinizing hormone (r-hLH) (2:1 ratio) versus r-hFSH alone fo...
The purpose of this study was to compare the immune response generated by the intramuscular and the intradermal vaccination route against the porcine reproductive and respiratory syndrome virus (PRRSV...
The prevalence of neural tube defects (NTDs) is higher in Ethiopia than most other countries, and ~84% of Ethiopian women of reproductive age (WRA) have folate insufficiency, a major risk factor for N...
The study is designed as a community-based, household-randomised, dose-response trial. A total of 360 non-pregnant WRA 18-49 years of age will be randomly assigned to one of three intervention arms: (...
The study has been approved by the Ethiopian Public Health Institute's Institutional Review Board, and the protocol has been registered with ClinicalTrials.gov (registration number NCT06223854). Study...
NCT06223854....
Ectopic pregnancy (EP) is defined as embryo implantation in a location other than the uterine cavity....
We aimed to evaluate the expression of several genes, which may play a role in EP, in the ampulla region of fallopian tubes and endometrial tissue of women with EP....
In this case-control study, 5 women who underwent salpingectomy due to EP, comprised the 5 pseudo-pregnant women as a control group. These participants referred to the Royan Institute, Shariati, and A...
The vascular endothelial growth factor expression was significantly higher in the ampulla region of the controls. However, no significant differences were observed in endometrial tissue. Assessments o...
Our results have strongly suggested that these genes play important roles in proper implantation, and disruptions in their expression patterns could lead to EP. However, more studies are needed to con...
Unscheduled bleeding on hormone replacement therapy (HRT) can affect up to 40% of users. In parallel with the increase in HRT prescribing in the UK, there has been an associated increase in referrals ...
Infant survival is an important factor in any community's health. Low birth weight affects babies not only during their infancy but also has long-term consequences for their health as adults. Unfortun...
The study used analytical cross-sectional study design to analyze secondary data from the Tanzania Demographic and Health Survey and Malaria Indicators Survey 2015-2016. A total of 4,644 women of repr...
The prevalence of LBW was 262(6.2%). After adjusting for confounders, the maternal factors associated with LBW were Age group of a pregnant woman [Less than 20 years (aOR = 1.907 CI = 1.134-3.205) in ...
The prevalence of low birth weight in Tanzania remains high. Women's age, parity, number of Antenatal care visits (ANC), and area of residence were found to be maternal factors associated with LBW. Th...
The unique sources of artistic inspiration and talent of twin artists are examined. The professional literature is rich with twin studies of creativity, but lacking when it comes to specific artistic ...